Araneta, Daisy G.

HRN: 18-94-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2026
CEFTRIAXONE 1G (VIAL)
06/07/2026
06/14/2026
IV
2g
1 Hour PTOR Then OD
Cholelithiasis With No Signs Of Cholecystitis For Open Cholecystectomy
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: